KRISTIN BIETZ: Open Payments
NPI 1144714205 · MITCHELL, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 18 payments from 15 companies in 2025. Trend: 2023 $157 · 2024 $322 · 2025 $404
Food & beverage: $286Education: $118
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 1 | $75 |
| Incyte Corporation | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| PFIZER INC. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| BeiGene USA, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Enhertu, MONJUVI, REBLOZYL, BRUKINSA, PLUVICTO, Lenvima, KEYTRUDA, IBRANCE.
Industry payments across SD — which companies pay providers there.
